Keyphrases
Biological Evaluation
100%
Synthetic Evaluation
100%
Design Evaluation
100%
Epidermal Growth Factor Receptor
100%
Proteolysis Targeting chimera (PROTAC)
100%
Receptor Proteolysis
100%
T790M
100%
Del19
100%
C797S mutation
100%
C797S
62%
EGFR mutation
25%
Receptor Degradation
25%
Cancer Patients
12%
In Cancer
12%
Small Molecule Inhibitors
12%
Therapeutic Agents
12%
Third Generation
12%
Non-small Cell Lung Cancer Patients
12%
Allosteric Inhibitor
12%
Degrader
12%
IC50
12%
Triple mutant
12%
Epidermal Growth Factor Receptor Inhibitors
12%
Inhibition Pathway
12%
Epidermal Growth Factor Receptor Protein
12%
Antiproliferation
12%
L858R/T790M
12%
Protein Degraders
12%
Evade
12%
Biochemistry, Genetics and Molecular Biology
Protein Catabolism
100%
Epidermal Growth Factor Receptor
100%
Small Molecule
8%
IC50
8%
Growth Factor Receptor Inhibitor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Receptor Protein
9%
Malignant Neoplasm
9%
Non Small Cell Lung Cancer
9%
Lead Compound
9%
Epidermal Growth Factor Receptor Kinase Inhibitor
9%
IC50
9%